Literature DB >> 15663511

UVA1 and UVB irradiated skin investigated by optical coherence tomography in vivo: a preliminary study.

T Gambichler1, B Künzlberger, V Paech, A Kreuter, S Boms, A Bader, G Moussa, M Sand, P Altmeyer, K Hoffmann.   

Abstract

In histological studies, it has frequently been demonstrated that ultraviolet (UV) exposure, in particular UVB, can induce significant thickening of the viable epidermis and/or stratum corneum. Since skin biopsy alters the original skin morphology and always requires an iatrogenic trauma, we aimed to introduce optical coherence tomography (OCT) in vivo for the investigation of changes of epidermal thickness (ET) following UVA1 and UVB irradiation. Twelve healthy subjects received daily 60 J/cm2 of UVA1 and 1.5 minimal erythema doses UVB on their upper back over 3 consecutive days. Twenty-four hours after the last irradiation, OCT assessments were performed on UV exposed and adjacent nonirradiated control sites. Data of ET as expressed by comparison of the averaged A-scans differed significantly between nonirradiated (94.2 +/- 15.7 microm), UVA1 (105.4 +/- 12.8 microm) and UVB (125.7 +/- 22.1 microm) exposed sites. In comparison to the nonirradiated sites, UVA1 exposed skin showed significant (P = 0.022) increase of ET of 11% and UVB exposed sites a significant (P < 0.001) increase of 25%. ET of UVA1 and UVB exposed skin sites differed significantly (P =0.005). Our results obtained from OCT in vivo measurements confirm data of previous histological studies indicating that not only erythemogenic doses of UVB, but also suberythemogenic doses of UVA1 may have a significant impact on ET. OCT appears to be a promising bioengineering technique for photobiological studies. However, further studies are needed to establish its measurement precision and validity, and to investigate in vivo spectral dependence on UV induced skin changes such as skin thickening.

Entities:  

Mesh:

Year:  2005        PMID: 15663511     DOI: 10.1111/j.1365-2230.2004.01690.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  7 in total

1.  Preliminary assessment of the risks associated with solar ultraviolet-A exposure.

Authors:  Boyan Petkov; Vito Vitale; Claudio Tomasi; Emanuela Gadaleta; Mauro Mazzola; Christian Lanconelli; Angelo Lupi; Maurizio Busetto; Elena Benedetti
Journal:  Radiat Environ Biophys       Date:  2010-09-28       Impact factor: 1.925

2.  Characterization of a human skin equivalent model to study the effects of ultraviolet B radiation on keratinocytes.

Authors:  Tara L Fernandez; Derek R Van Lonkhuyzen; Rebecca A Dawson; Michael G Kimlin; Zee Upton
Journal:  Tissue Eng Part C Methods       Date:  2014-06-03       Impact factor: 3.056

Review 3.  Optical Coherence Tomography Imaging of Normal, Chronologically Aged, Photoaged and Photodamaged Skin: A Systematic Review.

Authors:  Andrew Mamalis; Derek Ho; Jared Jagdeo
Journal:  Dermatol Surg       Date:  2015-09       Impact factor: 3.398

4.  Using optical coherence tomography to evaluate skin sun damage and precancer.

Authors:  Vrushali R Korde; Garret T Bonnema; Wei Xu; Chetankumar Krishnamurthy; James Ranger-Moore; Kathylynn Saboda; Lisa D Slayton; Stuart J Salasche; James A Warneke; David S Alberts; Jennifer K Barton
Journal:  Lasers Surg Med       Date:  2007-10       Impact factor: 4.025

Review 5.  [Optical coherence tomography for skin pathologies].

Authors:  J Welzel; S Schuh
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

6.  Motion correction of in vivo three-dimensional optical coherence tomography of human skin using a fiducial marker.

Authors:  Yih Miin Liew; Robert A McLaughlin; Fiona M Wood; David D Sampson
Journal:  Biomed Opt Express       Date:  2012-06-29       Impact factor: 3.732

7.  A quantitative and non-contact technique to characterise microstructural variations of skin tissues during photo-damaging process based on Mueller matrix polarimetry.

Authors:  Yang Dong; Honghui He; Wei Sheng; Jian Wu; Hui Ma
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.